These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35318284)

  • 1. Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subytpes.
    Chen M; Ohm DT; Phillips JS; McMillan CT; Capp N; Peterson C; Xie E; Wolk DA; Trojanowski JQ; Lee EB; Gee J; Grossman M; Irwin DJ
    J Neurosci; 2022 May; 42(18):3868-3877. PubMed ID: 35318284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
    Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
    Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
    Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.
    McMillan CT; Irwin DJ; Avants BB; Powers J; Cook PA; Toledo JB; McCarty Wood E; Van Deerlin VM; Lee VM; Trojanowski JQ; Grossman M
    J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):949-55. PubMed ID: 23475817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.
    Ohm DT; Peterson C; Lobrovich R; Cousins KAQ; Gibbons GS; McMillan CT; Wolk DA; Van Deerlin V; Elman L; Spindler M; Deik A; Siderowf A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol; 2020 Nov; 140(5):675-693. PubMed ID: 32804255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology.
    Burke SE; Phillips JS; Olm CA; Peterson CS; Cook PA; Gee JC; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M
    Neurobiol Aging; 2022 May; 113():95-107. PubMed ID: 35325815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration.
    Giannini LAA; Xie SX; Peterson C; Zhou C; Lee EB; Wolk DA; Grossman M; Trojanowski JQ; McMillan CT; Irwin DJ
    Front Neurosci; 2019; 13():682. PubMed ID: 31333403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia.
    Irwin DJ; McMillan CT; Xie SX; Rascovsky K; Van Deerlin VM; Coslett HB; Hamilton R; Aguirre GK; Lee EB; Lee VMY; Trojanowski JQ; Grossman M
    Brain; 2018 Jan; 141(1):288-301. PubMed ID: 29228211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies.
    Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW
    Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Event-based modeling of T1-weighted MRI is related to pathology in frontotemporal lobar degeneration due to tau and TDP.
    Olm CA; Burke SE; Peterson C; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M; Gee JC
    Neuroimage Clin; 2023; 37():103285. PubMed ID: 36508888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
    Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
    Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI signatures of the frontotemporal lobar degeneration continuum.
    Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
    Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia.
    Giannini LAA; Xie SX; McMillan CT; Liang M; Williams A; Jester C; Rascovsky K; Wolk DA; Ash S; Lee EB; Trojanowski JQ; Grossman M; Irwin DJ
    Ann Neurol; 2019 May; 85(5):630-643. PubMed ID: 30851133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
    Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
    Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.